Anbio Biotechnology (NNNN) › Cash & EquivalentsAnbio Biotechnology (NNNN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $9.69M2024: $11.76M2025: $7.77M$7.77M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$7.77M-34.0%2024$11.76M+21.4%2023$9.69M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share